Infection of specific strains of Streptococcus mutans, oral bacteria, confers a risk of ulcerative colitis

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Kojima, Ayuchi ^a   Nakano, Kazuhiko ^a   Wada, Koichiro ^a   Takahashi, Hirokazu ^b   Katayama, Kazufumi ^a   Yoneda, Masato ^b   Higurashi, Takuma ^b   Nomura, Ryota ^a   Hokamura, Kazuya ^c   Muranaka, Yoshinori ^c   Matsuhashi, Nobuyuki ^d   Umemura, Kazuo ^c   Kamisaki, Yoshinori ^a   Nakajima, Atsushi ^b   Ooshima, Takashi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Nippon Telegraph and Telephone Corporation Medical Center Tokyo   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ANIMAL; ARTICLE; BIOSYNTHESIS; HUMAN; LIVER; MICROBIOLOGY; MOUSE; MOUTH; PATHOGENICITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; STREPTOCOCCUS MUTANS; ULCERATIVE COLITIS;

ANIMALS; COLITIS, ULCERATIVE; CYTOKINES; HUMANS; LIVER; MICE; MOUTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; STREPTOCOCCUS MUTANS;

EID: 84859753092     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00332     Document Type: Article

References (28)

1. Blumberg, R. S. & Strober, W. Prospects for research in inflammatory bowel disease. JAMA 285, 643-647 (2001). (Pubitemid 32656339)
2. Shanahan, F. Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterol 120, 622-635 (2001). (Pubitemid 32171636)
3. Wada, K., Nakajima, A. & Blumberg, R. S. PPARgamma and inflammatory bowel disease: A new therapeutic target for ulcerative colitis and Crohn's disease. Trends Mol Med 7, 329-331 (2001). (Pubitemid 32735012)
4. Kaser, A. & Blumberg, R. S. Lesson from type I interferons in ulcerative colitis. Gut 60, 430-431 (2011).
5. Loftus, E. V. Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126, 1504-1517 (2004). (Pubitemid 38649869)
6. Nagalingam, N. A., Kao, J. Y. & Young, V. B. Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis. Inflamm Bowel Dis 17, 917-926 (2011).
7. Nell, S., Suerbaum, S. & Josenhans, C. The impact of the microbiota on the pathogenesis of IBD: Lessons from mouse infection models. Nat Rev Immunol 8, 564-577 (2010).
8. Saleh, M. & Trinchieri, G. Innate immune mechanisms of colitis and colitisassociated colorectal cancer. Nat Rev Immunol 11, 9-20 (2011).
9. Khan, K. J. et al. Antibiotic therapy in inflammatory bowel disease: A systematic review and meta-analysis. Am J Gastroenterol 106, 661-673 (2011).
10. Kinane, D. F., Riggio, M. P., Walker, K. F., MacKenzie, D. & Shearer, B. Bacteremia following periodontal procedures. J Clin Periodontol 32, 708-713 (2005).
11. Friedewald, V. E. et al. The Americal Journal of Cardiology and Journal of Periodontology Editors' consensus: periodontitis and atherosclerotic cardiovascular disease. Am J Cardiol 104, 59-68 (2009).
12. Wada, K. & Kamisaki, Y. Roles of oral bacteria in cardiovascular diseases-From molecular mechanisms to clinical cases: Involvement of Porphyromonas gingivalis in the development of human aortic aneurysm. J Pharmacol Sci 113, 115-119 (2010).
13. Wada, K. & Kamisaki, Y. Molecular dissection of Porphyromonas gingivalis-related arteriosclerosis: A novel mechanisms of vascular disease. Periodontol 2000 54, 222-234 (2010).
14. Moreillon, P. & Que, Y. A. Infective endocarditis. Lancet 363, 139-149 (2004). (Pubitemid 38068333)
15. Sconyer, J. R., Crawford, J. J. & Moriarty, J. D. Relationship of bacteremia to toothbrushing in patients with periodontitis. J AmDent Assoc 87, 616-622 (1973).
16. Lockhart, P. B. et al. Bacteremia associated with toothbrushing and dental extraction. Circulation 117, 3118-3125 (2008).
17. Nakano, K. et al. Demonstration of Streptococcus mutans with a cell wall polysaccharide specific to a new serotype, k, in the human oral cavity. J Clin Microbiol 42, 198-202 (2004). (Pubitemid 38082720)
18. Nakano, K. et al. Detection of novel serotype k Streptococcus mutans in infective endocarditis patients. J Med Microbiol 56, 1413-1415 (2007). (Pubitemid 350105615)
19. Ooshima, T., Izumitani, A., Sobue, S., Okahashi, N. & Hamada, S. Noncariogenicity of the disaccharide palatinose in experimental dental caries of rats. Infect Immun 39, 43-49 (1983). (Pubitemid 13212495)
20. Wada, K., Nakano, K., Ooshima, T. & Kamisaki, Y. Bacteremia by virulent oral bacteria is a potent risk factor for stroke under endothelial cell injury condition. J Pharmacol Sci 112:(Supple 1), 47P (2010).
21. Nakano, K. et al. The collagen-binding protein of Streptococcus mutans is involved in hemorrhagic stroke. Nat Commun DOI:10. 1038/ncomms1491 (2011).
22. Sato, Y. et al. Streptococcus mutans strains harboring collagen-binding adhesin. J Dent Res83, 534-539 (2004). (Pubitemid 41766081)
23. Nakano, K. et al. Molecular characterization of Streptococcus mutans strains containing the cnm gene encoding a collagen-binding adhesin. Arch Oral Biol 55, 34-39 (2010).
24. Nakano, K. et al. Protein antigen in serotype k Strepococcus mutans clinical isolates. J Dent Res 87, 964-968 (2008).
25. Saubermann, L. J. et al. Peroxisome proliferator-activated receptor gamma agonist ligands stimulate a Th2 cytokine response and prevent acute colitis. Inflamm Bowel Dis 8, 330-339 (2002).
26. Katayama, K. et al. A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model. Gastroentarol 124, 1315-1324 (2003). (Pubitemid 36531806)
27. Waterhouse, J. C. & Russell, R. R. B. Dispensable genes and foreign DNA in Streptococcus mutans. Microbiology 152, 1777-1788 (2006).
28. Nomura, R. et al. Molecular and clinical analyses of the gene encoding the collagen-binding adhesin of Streptococcus mutans. J Med Microbiol 58, 469-475 (2009).